JP2022543058A5 - - Google Patents
Info
- Publication number
- JP2022543058A5 JP2022543058A5 JP2022506469A JP2022506469A JP2022543058A5 JP 2022543058 A5 JP2022543058 A5 JP 2022543058A5 JP 2022506469 A JP2022506469 A JP 2022506469A JP 2022506469 A JP2022506469 A JP 2022506469A JP 2022543058 A5 JP2022543058 A5 JP 2022543058A5
- Authority
- JP
- Japan
- Prior art keywords
- tcr
- amino acid
- muc5ac
- acid sequence
- constant region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962880505P | 2019-07-30 | 2019-07-30 | |
| US62/880,505 | 2019-07-30 | ||
| PCT/IB2020/057171 WO2021019471A1 (en) | 2019-07-30 | 2020-07-29 | T cell receptors and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022543058A JP2022543058A (ja) | 2022-10-07 |
| JP2022543058A5 true JP2022543058A5 (https=) | 2023-08-08 |
| JP7669345B2 JP7669345B2 (ja) | 2025-04-28 |
Family
ID=74230247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506469A Active JP7669345B2 (ja) | 2019-07-30 | 2020-07-29 | Ｔ細胞受容体及びその使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220275047A1 (https=) |
| EP (1) | EP4004219A4 (https=) |
| JP (1) | JP7669345B2 (https=) |
| KR (1) | KR20220040489A (https=) |
| CN (1) | CN114450414B (https=) |
| AU (1) | AU2020320129A1 (https=) |
| BR (1) | BR112022001695A2 (https=) |
| CA (1) | CA3146302A1 (https=) |
| IL (1) | IL290221A (https=) |
| MX (1) | MX2022001207A (https=) |
| TW (1) | TWI881993B (https=) |
| WO (1) | WO2021019471A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3935175A4 (en) | 2019-03-04 | 2023-01-04 | University Health Network | T-LYMPHOCYTE RECEPTORS AND METHODS OF USE THEREOF |
| KR20220087431A (ko) | 2019-07-30 | 2022-06-24 | 유니버시티 헬스 네트워크 | T 세포 수용체 및 이의 사용 방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101363928B1 (ko) | 2007-06-11 | 2014-02-19 | 고쿠리츠다이가쿠호진 미에다이가쿠 | 특이적 유전자 발현 방법 |
| WO2011059836A2 (en) * | 2009-10-29 | 2011-05-19 | Trustees Of Dartmouth College | T cell receptor-deficient t cell compositions |
| US9273283B2 (en) * | 2009-10-29 | 2016-03-01 | The Trustees Of Dartmouth College | Method of producing T cell receptor-deficient T cells expressing a chimeric receptor |
| CA2884366A1 (en) * | 2012-09-12 | 2014-03-20 | International Institute Of Cancer Immunology, Inc. | Antigen-specific helper t-cell receptor genes |
| JP2018532801A (ja) * | 2015-10-30 | 2018-11-08 | ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 標的化がん療法 |
| WO2017185169A1 (en) | 2016-04-27 | 2017-11-02 | University Health Network (Uhn) | Pept1de-hla complexes and methods of producing same |
| KR20260026092A (ko) * | 2017-09-19 | 2026-02-25 | 메사추세츠 인스티튜트 오브 테크놀로지 | 키메라 항원 수용체 t 세포 요법을 위한 조성물 및 그의 용도 |
-
2020
- 2020-07-29 US US17/631,831 patent/US20220275047A1/en active Pending
- 2020-07-29 CA CA3146302A patent/CA3146302A1/en active Pending
- 2020-07-29 JP JP2022506469A patent/JP7669345B2/ja active Active
- 2020-07-29 BR BR112022001695A patent/BR112022001695A2/pt unknown
- 2020-07-29 EP EP20848269.5A patent/EP4004219A4/en active Pending
- 2020-07-29 MX MX2022001207A patent/MX2022001207A/es unknown
- 2020-07-29 AU AU2020320129A patent/AU2020320129A1/en active Pending
- 2020-07-29 CN CN202080064111.2A patent/CN114450414B/zh active Active
- 2020-07-29 TW TW109125669A patent/TWI881993B/zh active
- 2020-07-29 KR KR1020227006949A patent/KR20220040489A/ko active Pending
- 2020-07-29 WO PCT/IB2020/057171 patent/WO2021019471A1/en not_active Ceased
-
2022
- 2022-01-30 IL IL290221A patent/IL290221A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022527267A5 (https=) | ||
| JP2022523554A5 (https=) | ||
| JP2022523552A5 (https=) | ||
| JP2022524994A5 (https=) | ||
| JP2022524993A5 (https=) | ||
| JP2022523971A5 (https=) | ||
| Lowe et al. | Novel TCR-based biologics: mobilising T cells to warm ‘cold’tumours | |
| JP2022523553A5 (https=) | ||
| Baxevanis et al. | Cancer immunotherapy | |
| CN113286811B (zh) | 改善过继性细胞疗法的效力和安全性 | |
| CN113784733B (zh) | 靶向bcma的工程化免疫细胞及其用途 | |
| Kershaw et al. | Gene-engineered T cells for cancer therapy | |
| Houot et al. | T-cell–based immunotherapy: adoptive cell transfer and checkpoint inhibition | |
| US20190117692A1 (en) | Engager cells for immunotherapy | |
| JP2022531911A (ja) | Ｂｃｍａを標的とする操作された免疫細胞及びその使用 | |
| Zsiros et al. | Immunotherapy for ovarian cancer: recent advances and perspectives | |
| Essand et al. | Genetically engineered T cells for the treatment of cancer | |
| JP2022524992A5 (https=) | ||
| RU2018147423A (ru) | Анти-PD-L1 и IL-2 цитокины | |
| JP2022543059A5 (https=) | ||
| JP2021512637A5 (https=) | ||
| US11866504B2 (en) | Bispecific polypeptides for engagement of CAR expressing immune cells with antigen presenting cells and uses thereof | |
| JP2022521183A5 (https=) | ||
| WO2021223720A1 (zh) | 人源化cd19抗体及其应用 | |
| CA3052803A1 (en) | Maximizing t-cell memory and compositions and methods therefor |